Work

α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells

Year: 2015

Type: article

Source: Molecular Pharmacology

DOI: 10.1124/mol.115.100982

Authors: Arik J. Hone, J. Michael McIntosh, Layla Azam, Jon Lindstrom, Linda Lucero, Paul Whiteaker, Juan Passas, Jesús Blázquez, Almudena Albillos

Institutions: Barrow Neurological Institute, University of Utah, Hospital Clínico San Carlos, Hospital Universitario 12 De Octubre, University of Pennsylvania Health System, George E. Wahlen Department of VA Medical Center, Universidad Autónoma de Madrid, University of Pennsylvania

Language: English

Topic: Nicotinic Acetylcholine Receptors Study

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institute on Drug Abuse, National Institute of General Medical Sciences

Awards: G1513300592, Variants in CHRNA5/CHRNA3/CHRNB4 and nicotine dependence, G305540319, G3492364551, Construction and Expression of Concatemeric alpha6beta2* Nicotinic Acetycholine R, Conus Peptides and Their Receptor Targets: Towards Constellation Pharmacology., Development of a5* nAChR positive allosteric modulators for tobacco dependence, G5001361177, Novel nAChR-Targeted Peptides, Alpha-Conotoxin MII: A Selective Nicotinic Receptor Probe

OpenAlex ID: W1917275022

FWCI: 1.302

Cites: 67

Cited by: 34

Related to: 10